Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05911269 · ClinicalTrials.gov registry record · NA

Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors

A NA study of Anxiety, sponsored by University of Michigan Rogel Cancer Center.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05911269 is a NA study of Anxiety that is active but no longer recruiting, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 50 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05911269, a NA study of Anxiety, is active but no longer recruiting, sponsored by University of Michigan Rogel Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Demonstrate the feasibility of conducting an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in adolescent and young adult (AYA) cancer survivors with clinically-relevant anxiety.

Conditions Studied

Interventions

  • OTHER Control
  • OTHER TiMBRe

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-01-21
Est. Completion 2026-07
Phase NA

What the Registry Record Tells You About NCT05911269

The ClinicalTrials.gov registry entry for NCT05911269 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT05911269 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05911269 about?

NCT05911269 is a clinical study titled "Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors". Demonstrate the feasibility of conducting an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in adolescent and young adult (AYA) cancer survivors with clinically-relevant anxiety.

What is the current status of trial NCT05911269?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-01-21. Estimated completion is 2026-07.

What conditions does trial NCT05911269 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT05911269?

The interventions under investigation include: Control (OTHER), TiMBRe (OTHER).

Who is sponsoring clinical trial NCT05911269?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05911269 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.